Medical and Pharmaceutical Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st-line treatment China's National Medical Products Administration approved the initial new drug application in January Rowan DunneApril 25, 2025
Medical and Pharmaceutical NRx Pharmaceuticals submits NDA for intravenous ketamine drug This therapeutic is specifically designed for suicidal depression Rowan DunneMarch 19, 2025